Shalabh K. Gupta
Founder, Chairman, CEO & PresidentDr. Shalabh K. Gupta, M.D., MPA., Founded Unicycive Therapeutics, Inc. and serves as its Chairman of the Board and also serves as its Chief Executive Officer, President and Director since August 2016. He is Founder at Unicycive Therapeutics, Inc. He is the Founder of Globavir Biosciences, Inc. and serves as its Chief Executive Officer and President. Dr. Gupta has also served in various other capacities including founder and Chief Executive Officer of Biocycive Inc.; Strategy, Genentech Commercial at Genentech, Inc.; Equity Research, Pharmaceuticals at UBS Investment Bank; Attending Physician at NYU Medical Center; clinical faculty member at NYU School of Medicine; and Equity Research, Biotechnology at Rodman & Renshaw, LLC. In addition, he served on the board of directors of Beall Center for Innovation and Entrepreneurship at the University of California Irvine, Paul Merage School of Businesssince 2018. Dr. Gupta has also served as an advisor to SPARK, Stanford University School of Medicine since 2012, a charter member of TiE, a not-for-profit network of entrepreneurs fostering entrepreneurship, mentoring and education, since 2013. Dr. Gupta previously served on the board of directors of Phenomenome Discoveries Inc. and was a Fellow at the Startup Leadership Program, a medical advisor Synageva BioPharma Corporation (formerly known as AviGenics) and an advisor to NYU Langone Medical Center (Office of Technology Transfer). Dr. Gupta received his MPA in health care finance and management from NYU Robert F. Wagner Graduate School of Public Service and his MD medical degree from Jawaharlal Institute of Postgraduate Medical Education & Research, India. Furthermore, Dr. Gupta completed his internship in Internal Medicine and medical residency in physical medicine and rehabilitation and a research fellowship in cardiopulmonary rehabilitation from New York University (“NYU”) School of Medicine and New York University. He practiced medicine from 2000 to 2008 at NYU’s various hospitals first during his medical training (2000-2004) and then as an attending physician (2004-2008). Dr. Gupta also served as a faculty member at NYU School of Medicine. In the past, Dr. Gupta was a board-certified physician and he currently holds a license from the California State Medical Board. While working as a stock analyst on Wall Street, Dr. Gupta held Series 7, 63, 86 and 87 licenses.
Positions
- Company NameUnicycive Therapeutics, Inc.Stock CodeUNCYPositionFounder, Chairman, CEO & PresidentColleagues
- PGPramod GuptaExecutive Vice President of Pharmaceutical and Business Operations
- DJDouglas JermasekExecutive Vice President of Corporate Strategy
- JWJohn W. TownsendChief Financial Officer
- SLSandeep LaumasIndependent Director
- SKSaraswati Kenkare-MitraIndependent Director
- MSMeredith S. ManningIndependent Director
- RLRavindra L. MehtaMember of Scientific Advisory Board
